Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 188
interventional 152
Observational 33
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 103
Drug|placebo 17
Other 11
Biological|placebo 3
Device 3
Dietary Supplement|placebo 3
Biological 2
Diagnostic Test 2
Behavioral 1
Behavioral|Drug|Procedure 1
Biological|Drug 1
Device|Drug 1
Diagnostic Test|Drug 1
Dietary Supplement 1
Drug|Other 1
Drug|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 55
NA 14
France 7
Brazil 6
Italy 5
Austria 3
China 3
Spain 3
Germany 2
Israel 2
Japan 2
Korea, Republic of 2
Netherlands 2
Taiwan 2
United States|Canada 2
Argentina|Brazil|Peru|South Africa 1
Australia 1
Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Portugal|Romania|Russian Federation|Slovakia|Turkey|Ukraine|United Kingdom 1
Austria|Belgium|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Romania|Spain|Switzerland|Turkey|United Kingdom 1
Austria|France|Germany|Italy|Poland|Spain|Sweden|United Kingdom 1
Belgium 1
Belgium|Switzerland 1
Botswana|India|Kenya|Malawi|South Africa|Uganda|Zimbabwe 1
Brazil|Chile|Colombia|Mexico|Panama 1
Brazil|Peru|South Africa 1
Canada|United States 1
Denmark 1
Dominican Republic 1
France|United States|Argentina|Belgium|Canada|Chile|Dominican Republic|Ethiopia|Germany|Guatemala|Honduras|Israel|Mexico|Panama|South Africa|Spain|Thailand|Venezuela 1
Germany|Russian Federation 1
Ghana|Guinea|Togo 1
India 1
Malawi 1
Malaysia 1
Panama|South Africa 1
Rwanda 1
Spain|United States|Austria|Belgium|Brazil|Canada|Croatia|Czech Republic|France|Germany|India|Netherlands|Poland|Switzerland|United Kingdom 1
Sweden 1
Switzerland 1
Tanzania 1
Thailand 1
Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|France|Germany|Hungary|India|Israel|Italy|Lebanon|Malaysia|Mexico|New Zealand|Philippines|Russian Federation|Singapore|South Africa|Spain|Switzerland|Thailand 1
United States|Australia|Belgium|Bulgaria|Greece|Israel|Italy|Korea, Republic of|Spain 1
United States|Austria|Germany|Netherlands|Spain|United Kingdom 1
United States|Barbados 1
United States|Belgium|Bulgaria|Canada|Greece|Hungary|Italy|Romania|Russian Federation|Spain 1
United States|Brazil|Canada|Greece|Italy|Korea, Republic of|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Bulgaria 1
United States|El Salvador|Germany|Guatemala|Honduras 1
United States|India|Pakistan|South Africa 1
United States|Kenya 1
United States|Korea, Republic of 1
United States|Puerto Rico 1
United States|Puerto Rico|Tanzania 1
United States|South Africa 1
United States|Tanzania 1

Sites per Study

Site_count Study_Count
1 79
2 10
3 3
4 2
5 2
6 3
7 1
8 1
9 1
10 4
12 1
13 3
14 2
16 1
17 2
18 4
19 1
20 2
22 1
23 2
24 1
25 3
26 1
27 1
30 2
31 1
32 2
33 1
37 2
41 1
42 1
43 1
44 1
45 1
53 1
54 1
56 1
61 1
63 1
73 1
113 1
167 1

Phase

Phase Study_Count
Phase 3 44
N/A 40
Phase 2 29
Phase 4 22
Phase 1 13
Phase 1/Phase 2 2
Early Phase 1 1
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 26
2 57
3 15
4 11
5 1
6 1
NA 41

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 30 5.0000 9 90.0 13.0000 84 24.0000 7.0000
1st Qu. 30 36.0000 24 114.5 35.0000 84 174.2500 49.5000
Median 30 100.0000 34 139.0 96.0000 84 300.0000 89.5000
Mean 30 172.6897 50 139.0 121.6207 84 345.8409 158.9091
3rd Qu. 30 250.0000 48 163.5 208.0000 84 456.0000 202.5000
Max. 30 611.0000 164 188.0 500.0000 84 1524.0000 948.0000

Trial Group Type

group_type Group_Count
Experimental 131
Active Comparator 65
NA 41
Placebo Comparator 26
Other 15
No Intervention 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 87
Single Group Assignment 36
NA 24
Crossover Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 112
Prevention 24
Diagnostic 6
Other 4
NA 3
Basic Science 1
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 8
France 4
Netherlands 4
Austria 3
Germany 2
Spain 2
Belgium 1
India 1
Kazakhstan 1
Korea, Republic of 1
NA 1
Rwanda 1
Saudi Arabia 1
Switzerland 1
Taiwan 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 23
2 4
3 1
6 1
10 1
20 1
23 1
27 1

Enrollment Metrics

Measure Observational
Min 15.0000
1st Qu 50.0000
Median 219.5000
Mean 727.5312
3rd Qu 405.5000
Max 13024.0000

Observation Model

observational_model Study_Count
Cohort 13
Case-Only 10
NA 4
Case-Control 2
Case Control 2
Other 2

Time Perspective

time_perspective Study_Count
Prospective 22
Retrospective 6
NA 3
Cross-Sectional 1
Other 1

Registries

Studies by Country

Country Study_Count
China 1
France 1
United States|Canada|Colombia|Greece|India|Italy|Saudi Arabia|Spain 1

Sites per Study

Site_count Study_Count
1 1
4 1
35 1

Enrollment Metrics

Measure Registries
Min 200.0000
1st Qu 350.0000
Median 500.0000
Mean 483.3333
3rd Qu 625.0000
Max 750.0000

Registry Model

observational_model Study_Count
Cohort 3

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
1 Month 1
10 Days 1
7 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT01994096 Optimal Dosage of Caspofungin in Critically Ill Patients https://ClinicalTrials.gov/show/NCT01994096 Completed University Medical Center Groningen 2015-10-31
NCT03363841 Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) https://ClinicalTrials.gov/show/NCT03363841 Recruiting Scynexis, Inc. 2020-11-15
NCT03203551 Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. https://ClinicalTrials.gov/show/NCT03203551 Completed University of Sao Paulo 2016-01-01
NCT03140748 Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation https://ClinicalTrials.gov/show/NCT03140748 Recruiting Centre Hospitalier Universitaire, Amiens 2020-06-01
NCT03115073 ProF-001_Phase IIa https://ClinicalTrials.gov/show/NCT03115073 Completed ProFem GmbH 2018-07-30
NCT03090334 A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis https://ClinicalTrials.gov/show/NCT03090334 Recruiting University of Bologna 2020-06-30
NCT03059992 Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment https://ClinicalTrials.gov/show/NCT03059992 Recruiting Scynexis, Inc. 2021-09-30
NCT02971007 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) https://ClinicalTrials.gov/show/NCT02971007 Completed Matinas BioPharma Nanotechnologies, Inc. 2017-05-31
NCT02866227 TOL-463 Phase 2 Study for Vaginitis https://ClinicalTrials.gov/show/NCT02866227 Completed Toltec Pharmaceuticals, LLC 2017-06-10
NCT02860845 Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections https://ClinicalTrials.gov/show/NCT02860845 Completed Laboratorios Ordesa 2017-10-16
NCT02818803 Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic https://ClinicalTrials.gov/show/NCT02818803 Completed University of Sao Paulo 2016-06-30
NCT02795845 Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study https://ClinicalTrials.gov/show/NCT02795845 Recruiting HaEmek Medical Center, Israel 2021-07-31
NCT02734862 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension https://ClinicalTrials.gov/show/NCT02734862 Completed Cidara Therapeutics Inc. 2019-06-30
NCT02734550 (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis https://ClinicalTrials.gov/show/NCT02734550 Completed Center for Sepsis Control and Care, Germany 2019-08-22
NCT02733432 RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections https://ClinicalTrials.gov/show/NCT02733432 Completed Cidara Therapeutics Inc. 2016-11-23
NCT02730494 Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation https://ClinicalTrials.gov/show/NCT02730494 Completed Biose 2016-01-31
NCT02679456 Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02679456 Completed Scynexis, Inc. 2016-08-05
NCT02631954 Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02631954 Completed Chong Kun Dang Pharmaceutical 2015-10-31
NCT02493738 A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02493738 Completed Boryung Pharmaceutical Co., Ltd 2015-10-31
NCT02391532 Effect of Probiotic Bacteria on Oral Candida in Frail Elderly https://ClinicalTrials.gov/show/NCT02391532 Completed University of Copenhagen 2014-03-31
NCT02267382 A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) https://ClinicalTrials.gov/show/NCT02267382 Completed Viamet 2016-11-09
NCT02251093 Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02251093 Completed Probionov 2016-02-29
NCT02248506 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02248506 Completed Instituto Palacios 2015-03-31
NCT02244606 Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis https://ClinicalTrials.gov/show/NCT02244606 Completed Scynexis, Inc. 2016-06-30
NCT02242695 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02242695 Completed Medinova AG 2015-12-31
NCT02184351 Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis https://ClinicalTrials.gov/show/NCT02184351 Completed Boehringer Ingelheim 2001-11-30
NCT02180828 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02180828 Completed Peking University Shenzhen Hospital 2015-09-30
NCT02180100 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT02180100 Completed Peking University Shenzhen Hospital 2014-06-30
NCT02164890 Pharmacokinetics of Micafungin in Patients of Intensive Care Units https://ClinicalTrials.gov/show/NCT02164890 Completed University Hospital, Limoges 2015-12-31
NCT02150655 Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women https://ClinicalTrials.gov/show/NCT02150655 Completed Western University, Canada 2013-09-30
NCT01293643 A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) https://ClinicalTrials.gov/show/NCT01293643 Completed Merck Sharp & Dohme Corp. 2011-01-31
NCT01273922 Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida https://ClinicalTrials.gov/show/NCT01273922 Completed NovaDigm Therapeutics, Inc. 2011-10-31
NCT01926028 Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT01926028 Completed NovaDigm Therapeutics, Inc. 2015-05-31
NCT01916057 Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis https://ClinicalTrials.gov/show/NCT01916057 Completed Assistance Publique - Hôpitaux de Paris 2017-06-01
NCT01891331 A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) https://ClinicalTrials.gov/show/NCT01891331 Completed Viamet 2014-12-31
NCT00835029 Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches https://ClinicalTrials.gov/show/NCT00835029 Completed Hadassah Medical Organization 2012-02-29
NCT01806623 The Study Of Fluconazole For Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT01806623 Completed Pfizer 2013-11-22
NCT01773876 Empirical Antifungal Treatment in ICUS https://ClinicalTrials.gov/show/NCT01773876 Completed University Hospital, Grenoble 2015-02-28
NCT01666769 Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT01666769 Completed Duke University 2016-02-02
NCT01497223 MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT01497223 Completed MethylGene Inc. 2013-04-30
NCT01495039 Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients https://ClinicalTrials.gov/show/NCT01495039 Completed Policlinico Hospital 2009-08-31
NCT01427738 Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis https://ClinicalTrials.gov/show/NCT01427738 Completed AIDS Clinical Trials Group 2012-09-30
NCT04410250 Effect of Oral Hygienization in Newborn on Candida Spp Colonization https://ClinicalTrials.gov/show/NCT04410250 Recruiting Federal University of the Valleys of Jequitinhonha and Mucuri 2020-08-06
NCT03561701 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) https://ClinicalTrials.gov/show/NCT03561701 Active, not recruiting Mycovia Pharmaceuticals Inc. 2020-07-20
NCT04368559 Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation https://ClinicalTrials.gov/show/NCT04368559 Recruiting Cidara Therapeutics Inc. 2022-03-31
NCT04292704 A Protocol for the Role of Fractional CO2 Laser in Consolidation Treatment of Recurrent Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT04292704 Recruiting Second Affiliated Hospital of Wenzhou Medical University 2022-03-31
NCT04148287 An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris https://ClinicalTrials.gov/show/NCT04148287 Recruiting Amplyx Pharmaceuticals 2020-05-15
NCT04122560 Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration https://ClinicalTrials.gov/show/NCT04122560 Recruiting Radboud University 2020-08-01
NCT04029116 Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) https://ClinicalTrials.gov/show/NCT04029116 Recruiting Scynexis, Inc. 2021-06-30
NCT03987620 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT03987620 Active, not recruiting Scynexis, Inc. 2020-03-31
NCT03975569 Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis https://ClinicalTrials.gov/show/NCT03975569 Completed University Hospital, Antwerp 2017-03-31
NCT03940612 Probiotic for Vaginal Candidiasis in Pregnant Women https://ClinicalTrials.gov/show/NCT03940612 Recruiting Universiti Sains Malaysia 2020-03-24
NCT03906916 Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin https://ClinicalTrials.gov/show/NCT03906916 Recruiting Fadoi Foundation, Italy 2020-01-31
NCT03894839 Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species https://ClinicalTrials.gov/show/NCT03894839 Completed Yuzuncu Yıl University 2018-10-26
NCT03873753 Relationship Between Oral Hygiene in Newborns and Candida Spp. https://ClinicalTrials.gov/show/NCT03873753 Recruiting Faculty Sao Leopoldo Mandic Campinas 2020-07-31
NCT03840616 A Study of Oral VT-1161 for the Treatment of Acute Vaginal Candidiasis (Yeast Infection) in Patients With Recurrent Vaginal Candidiasis https://ClinicalTrials.gov/show/NCT03840616 Recruiting Mycovia Pharmaceuticals Inc. 2020-07-31
NCT03828773 PTX3-targeted Antifungal Prophylaxis https://ClinicalTrials.gov/show/NCT03828773 Recruiting Centre Hospitalier Universitaire Vaudois 2022-07-31
NCT03761628 Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT03761628 Completed Gedea Biotech AB 2019-12-16
NCT03734991 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) https://ClinicalTrials.gov/show/NCT03734991 Completed Scynexis, Inc. 2019-08-21
NCT03717623 Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants https://ClinicalTrials.gov/show/NCT03717623 Recruiting Melbourne Health 2020-06-30
NCT03630770 Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida https://ClinicalTrials.gov/show/NCT03630770 Recruiting Women and Infants Hospital of Rhode Island 2020-12-31
NCT03538912 Early Discontinuation of Empirical Antifungal Therapy and Biomarkers https://ClinicalTrials.gov/show/NCT03538912 Recruiting University Hospital, Lille 2021-05-31
NCT03468803 Influence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (BDG) Values https://ClinicalTrials.gov/show/NCT03468803 Completed Medical University of Graz 2019-01-17
NCT03421002 Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis https://ClinicalTrials.gov/show/NCT03421002 Completed Astellas Pharma Inc 2018-04-10
NCT01237795 Experimental Denture Pastes https://ClinicalTrials.gov/show/NCT01237795 Completed University of Sao Paulo 2008-06-30
NCT01237782 Efficacy of a Propolis-based Denture Cleanser https://ClinicalTrials.gov/show/NCT01237782 Completed University of Sao Paulo 2011-06-30
NCT01230814 Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women https://ClinicalTrials.gov/show/NCT01230814 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-08-31
NCT01165320 A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) https://ClinicalTrials.gov/show/NCT01165320 Completed Merck Sharp & Dohme Corp. 2013-09-17
NCT01144286 Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment https://ClinicalTrials.gov/show/NCT01144286 Completed Ferrer Internacional S.A. 2011-03-31
NCT01122368 A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects https://ClinicalTrials.gov/show/NCT01122368 Completed Astellas Pharma Inc 2011-12-15
NCT01102387 Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections https://ClinicalTrials.gov/show/NCT01102387 Completed Almirall, S.A. 2011-07-31
NCT01067131 Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection https://ClinicalTrials.gov/show/NCT01067131 Completed Pevion Biotech Ltd 2012-12-31
NCT01039584 A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations https://ClinicalTrials.gov/show/NCT01039584 Completed Perrigo Company 2009-09-30
NCT00895453 Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) https://ClinicalTrials.gov/show/NCT00895453 Completed Medical University of Vienna 2006-02-28
NCT02641717 Validity of Patient-Collected Wet Mounts https://ClinicalTrials.gov/show/NCT02641717 Completed The University of Texas Health Science Center at San Antonio 2016-07-31
NCT01769339 An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis https://ClinicalTrials.gov/show/NCT01769339 Completed Janssen Pharmaceutica 2009-06-30
NCT03562156 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) https://ClinicalTrials.gov/show/NCT03562156 Active, not recruiting Mycovia Pharmaceuticals Inc. 2020-07-20
NCT03253094 An Active-Controlled, Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT03253094 Completed Scynexis, Inc. 2018-05-04
NCT01447407 Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine https://ClinicalTrials.gov/show/NCT01447407 Completed NovaDigm Therapeutics, Inc. 2012-03-31
NCT00803738 Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT00803738 Completed Perrigo Company 2003-12-31
NCT03024502 Patients With Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT03024502 Recruiting University of Sao Paulo 2020-01-31
NCT02629419 CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis https://ClinicalTrials.gov/show/NCT02629419 Active, not recruiting Matinas BioPharma Nanotechnologies, Inc. 2021-01-31
NCT03667690 Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis https://ClinicalTrials.gov/show/NCT03667690 Recruiting Cidara Therapeutics Inc. 2020-09-30
NCT01743690 The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus https://ClinicalTrials.gov/show/NCT01743690 Completed University of Copenhagen 2015-12-31
NCT00784368 A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection https://ClinicalTrials.gov/show/NCT00784368 Completed Janssen Pharmaceutical K.K. 2009-04-30
NCT00768794 Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT00768794 Completed Summa Health System 2010-03-31
NCT00761267 Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00761267 Completed Pfizer 2018-02-28
NCT00755053 Comparative Efficacy of Ovule vs Tablet https://ClinicalTrials.gov/show/NCT00755053 Completed Bayer 2009-05-31
NCT00739934 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection https://ClinicalTrials.gov/show/NCT00739934 Completed Pfizer 2009-10-31
NCT00734539 Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight https://ClinicalTrials.gov/show/NCT00734539 Completed Duke University 2011-12-31
NCT00689338 Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study https://ClinicalTrials.gov/show/NCT00689338 Completed Pfizer 2010-05-31
NCT00672841 β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients https://ClinicalTrials.gov/show/NCT00672841 Completed Duke University 2010-12-31
NCT00670657 CRITIC - Treatment of Candidemia and Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00670657 Completed Gilead Sciences 2008-12-31
NCT00666185 Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis https://ClinicalTrials.gov/show/NCT00666185 Completed Astellas Pharma Inc 2004-02-29
NCT00665639 Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis https://ClinicalTrials.gov/show/NCT00665639 Completed Astellas Pharma Inc 2004-12-31
NCT00659971 Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis https://ClinicalTrials.gov/show/NCT00659971 Completed Pacgen Biopharmaceuticals Corporation 2008-06-30
NCT00647907 A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections https://ClinicalTrials.gov/show/NCT00647907 Completed Pfizer NA
NCT00635648 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) https://ClinicalTrials.gov/show/NCT00635648 Completed Merck Sharp & Dohme Corp. 2011-05-31
NCT00608335 Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug https://ClinicalTrials.gov/show/NCT00608335 Completed Astellas Pharma Inc 2011-09-08
NCT00607763 Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug https://ClinicalTrials.gov/show/NCT00607763 Completed Astellas Pharma Inc 2009-10-31
NCT00553137 Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania https://ClinicalTrials.gov/show/NCT00553137 Completed Netherlands Organisation for Scientific Research 2007-12-31
NCT00548262 This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00548262 Completed Pfizer 2009-10-31
NCT00520234 Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) https://ClinicalTrials.gov/show/NCT00520234 Completed Mycoses Study Group 2010-03-31
NCT00496197 Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00496197 Completed Pfizer 2010-06-30
NCT00413218 Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections https://ClinicalTrials.gov/show/NCT00413218 Completed Astellas Pharma Inc 2015-03-03
NCT00390780 Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients https://ClinicalTrials.gov/show/NCT00390780 Completed Onxeo 2007-12-31
NCT00353561 Diabetes Mellitus and Vulvovaginal Candidiasis https://ClinicalTrials.gov/show/NCT00353561 Completed Indian Council of Medical Research 2006-04-30
NCT00330395 Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) https://ClinicalTrials.gov/show/NCT00330395 Completed Merck Sharp & Dohme Corp. 2006-10-31
NCT00313131 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments https://ClinicalTrials.gov/show/NCT00313131 Completed Université de Sherbrooke NA
NCT00250432 A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) https://ClinicalTrials.gov/show/NCT00250432 Completed Merck Sharp & Dohme Corp. 2008-01-31
NCT00194324 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina https://ClinicalTrials.gov/show/NCT00194324 Completed University of Pennsylvania NA
NCT00189709 Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia https://ClinicalTrials.gov/show/NCT00189709 Completed Astellas Pharma Inc 2006-07-31
NCT00163111 A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. https://ClinicalTrials.gov/show/NCT00163111 Completed Pfizer NA
NCT00128323 A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis https://ClinicalTrials.gov/show/NCT00128323 Completed University of Malawi College of Medicine NA
NCT00106288 Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia https://ClinicalTrials.gov/show/NCT00106288 Completed Astellas Pharma Inc 2005-12-31
NCT00105144 Study of Micafungin in Patients With Invasive Candidiasis or Candidemia https://ClinicalTrials.gov/show/NCT00105144 Completed Astellas Pharma Inc 2006-04-30
NCT00099775 Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units https://ClinicalTrials.gov/show/NCT00099775 Completed National Institutes of Health Clinical Center (CC) NA
NCT00083343 Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) https://ClinicalTrials.gov/show/NCT00083343 Completed Merck Sharp & Dohme Corp. 2006-02-28
NCT00082524 Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) https://ClinicalTrials.gov/show/NCT00082524 Completed Merck Sharp & Dohme Corp. 2007-07-31
NCT00058682 Anidulafungin Versus Fluconazole in the Treatment of Candidemia https://ClinicalTrials.gov/show/NCT00058682 Completed National Institutes of Health Clinical Center (CC) NA
NCT00056368 The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00056368 Completed Pfizer NA
NCT00797420 Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers https://ClinicalTrials.gov/show/NCT00797420 Completed Duke University 2010-01-31
NCT00005912 Voriconazole to Prevent Systemic Fungal Infections in Children https://ClinicalTrials.gov/show/NCT00005912 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001937 Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients https://ClinicalTrials.gov/show/NCT00001937 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001812 A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 https://ClinicalTrials.gov/show/NCT00001812 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001810 An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections https://ClinicalTrials.gov/show/NCT00001810 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041704 The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) https://ClinicalTrials.gov/show/NCT00041704 Completed Pfizer NA
NCT00001542 Fluconazole Prophylaxis of Thrush in AIDS https://ClinicalTrials.gov/show/NCT00001542 Completed National Institutes of Health Clinical Center (CC) NA
NCT00037219 The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. https://ClinicalTrials.gov/show/NCT00037219 Completed Pfizer NA
NCT00036179 Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis https://ClinicalTrials.gov/show/NCT00036179 Completed Astellas Pharma Inc 2002-01-27
NCT00005921 A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis https://ClinicalTrials.gov/show/NCT00005921 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002446 Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT00002446 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002431 The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00002431 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002399 A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT00002399 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002394 Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment https://ClinicalTrials.gov/show/NCT00002394 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002341 A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole https://ClinicalTrials.gov/show/NCT00002341 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002339 A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems https://ClinicalTrials.gov/show/NCT00002339 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002304 A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems https://ClinicalTrials.gov/show/NCT00002304 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002293 A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes https://ClinicalTrials.gov/show/NCT00002293 Completed Bristol-Myers Squibb NA
NCT00002282 A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS https://ClinicalTrials.gov/show/NCT00002282 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002133 An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. https://ClinicalTrials.gov/show/NCT00002133 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002132 Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. https://ClinicalTrials.gov/show/NCT00002132 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002112 Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00002112 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002057 Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC https://ClinicalTrials.gov/show/NCT00002057 Completed Bristol-Myers Squibb NA
NCT00002041 Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients https://ClinicalTrials.gov/show/NCT00002041 Completed Bristol-Myers Squibb NA
NCT00002038 Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy https://ClinicalTrials.gov/show/NCT00002038 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001107 Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants https://ClinicalTrials.gov/show/NCT00001107 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001065 A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole https://ClinicalTrials.gov/show/NCT00001065 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000951 A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush https://ClinicalTrials.gov/show/NCT00000951 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000788 A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone https://ClinicalTrials.gov/show/NCT00000788 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000744 A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women https://ClinicalTrials.gov/show/NCT00000744 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000676 Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) https://ClinicalTrials.gov/show/NCT00000676 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03136081 Candida Host Defense Response After Septic Shock in the Critically Ill https://ClinicalTrials.gov/show/NCT03136081 Completed University Hospital, Montpellier 2015-05-31
NCT03064789 Epidemiological Study in Subjects With Vulvovaginal Candidiases https://ClinicalTrials.gov/show/NCT03064789 Recruiting Instituto Palacios 2019-03-30
NCT03045809 Women’s Improvement of Sexual Health (WISH) Demonstration Project https://ClinicalTrials.gov/show/NCT03045809 Completed University of Liverpool 2017-03-14
NCT02888197 Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization https://ClinicalTrials.gov/show/NCT02888197 Completed Cidara Therapeutics Inc. 2017-03-15
NCT02841501 Genetic Susceptibility Factors for Candidemia. https://ClinicalTrials.gov/show/NCT02841501 Recruiting University Hospital, Lille 2019-07-31
NCT02801682 NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis https://ClinicalTrials.gov/show/NCT02801682 Recruiting Medical University of Graz 2020-10-31
NCT02666716 Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients https://ClinicalTrials.gov/show/NCT02666716 Completed Radboud University 2016-03-31
NCT02491151 Variability of Fluconazole Concentration in Critically Ill Patients https://ClinicalTrials.gov/show/NCT02491151 Completed University Medical Center Groningen 2016-12-31
NCT02413892 Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients https://ClinicalTrials.gov/show/NCT02413892 Completed Outcome Rea 2017-01-31
NCT02203942 Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis https://ClinicalTrials.gov/show/NCT02203942 Completed University of Pittsburgh 2015-06-30
NCT01919931 Immunological Interaction Between the Host and Candida Albicans Biofilm https://ClinicalTrials.gov/show/NCT01919931 Completed Universitaire Ziekenhuizen Leuven 2015-08-31
NCT01716988 Pharmacokinetics of Micafungin in Critically Ill Patients https://ClinicalTrials.gov/show/NCT01716988 Completed University Medical Center Groningen 2016-12-31
NCT01490684 Invasive Candidiasis in Saudi ICUs https://ClinicalTrials.gov/show/NCT01490684 Completed King Abdulaziz Medical City 2016-05-31
NCT01335373 Observational Program Neo-Penotran® Forte https://ClinicalTrials.gov/show/NCT01335373 Completed Bayer 2011-12-31
NCT01322698 Staging Candidiasis in ICU Patients https://ClinicalTrials.gov/show/NCT01322698 Completed Centre Hospitalier Universitaire de Nīmes 2014-10-31
NCT04287504 Point-of-care Tests for Bacterial Vaginosis and Candidosis https://ClinicalTrials.gov/show/NCT04287504 Recruiting Medical University of Vienna 2020-12-31
NCT03993093 Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre https://ClinicalTrials.gov/show/NCT03993093 Completed Singh, Ranjan Kumar, M.D. 2020-02-28
NCT03641131 Ampholipad Real-World Data in Taiwan https://ClinicalTrials.gov/show/NCT03641131 Completed Taiwan Liposome Company 2019-01-02
NCT03450005 ECMM Candida Registry - CandiReg https://ClinicalTrials.gov/show/NCT03450005 Recruiting University of Cologne 2022-01-31
NCT01207843 Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias https://ClinicalTrials.gov/show/NCT01207843 Completed University of Zurich 2011-04-30
NCT01202253 Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom https://ClinicalTrials.gov/show/NCT01202253 Completed Pfizer 2011-05-31
NCT01047267 Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) https://ClinicalTrials.gov/show/NCT01047267 Completed University Medical Center Groningen 2011-11-30
NCT01040156 Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01040156 Completed University Children’s Hospital Tuebingen 2009-12-31
NCT00802854 Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV https://ClinicalTrials.gov/show/NCT00802854 Completed Pfizer 2016-05-20
NCT01386437 Natural History of Individuals With Immune System Problems That Lead to Fungal Infections https://ClinicalTrials.gov/show/NCT01386437 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00786903 Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen? https://ClinicalTrials.gov/show/NCT00786903 Completed Medical University of Graz 2015-04-30
NCT00612963 Novel Rinse to Treat in Oral Candidiasis in Cancer Patients https://ClinicalTrials.gov/show/NCT00612963 Completed Biomedical Development Corporation 2009-05-31
NCT00388167 Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection https://ClinicalTrials.gov/show/NCT00388167 Completed PETHEMA Foundation NA
NCT00366223 Changing Patterns of Candida Infections in Urban Medical Centers https://ClinicalTrials.gov/show/NCT00366223 Completed University of Pittsburgh 2017-06-30
NCT00138502 Funguria in Hospitalized Patients https://ClinicalTrials.gov/show/NCT00138502 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-12-08
NCT00109525 Early Diagnosis of Candidiasis in Premature Infants https://ClinicalTrials.gov/show/NCT00109525 Completed NICHD Neonatal Research Network 2007-07-31
NCT00001448 The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection https://ClinicalTrials.gov/show/NCT00001448 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004781 Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups https://ClinicalTrials.gov/show/NCT00004781 Completed Office of Rare Diseases (ORD) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01869829 PEACE: Pediatric Antifungal Comparative Effectiveness https://ClinicalTrials.gov/show/NCT01869829 Completed Duke University 2018-04-30
NCT03997929 Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2) https://ClinicalTrials.gov/show/NCT03997929 Recruiting Central Hospital, Nancy, France 2020-09-01
NCT03766932 Antigenic and Antibody Detection of Candida https://ClinicalTrials.gov/show/NCT03766932 Recruiting Chinese PLA General Hospital 2018-12-31